GC-rich promoter elements maximally confers estrogen-induced transactivation of LRP16 gene through ERα/Sp1 interaction in MCF-7 cells

Journal of Steroid Biochemistry and Molecular Biology

Volumn 109, Issue 1-2, 2008, Pages 47-56

  Han, Wei Dong ^a   Si, Yi Ling ^a   Zhao, Ya Li ^a   Li, Qi ^a   Wu, Zhi Qiang ^a   Hao, Hao Jie ^a   Song, Hai Jing ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Estrogen receptor ; GC rich site; LRP16; Sp1

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR ALPHA; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR SP1;

ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GC RICH SEQUENCE; GEL MOBILITY SHIFT ASSAY; GENE; GENE CONTROL; GENE DELETION; GENE MUTATION; HUMAN; HUMAN CELL; LRP16 GENE; NORTHERN BLOTTING; PROTEIN BINDING; PROTEIN INTERACTION; TRANSACTIVATION; UPREGULATION;

BASE SEQUENCE; BINDING SITES; BREAST NEOPLASMS; CELL LINE, TUMOR; DNA, NEOPLASM; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FEMALE; GC RICH SEQUENCE; HELA CELLS; HUMANS; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; PROMOTER REGIONS (GENETICS); RNA, SMALL INTERFERING; SP1 TRANSCRIPTION FACTOR; TRANS-ACTIVATION (GENETICS);

EID: 40849113025     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2007.12.009     Document Type: Article

References (44)

1. Farhat M.Y., Lavigne M.C., and Ramwell P.W. The vascular protective effects of estrogen. FASEB J. 10 5 (1996) 615-624
2. Turner R.T., Riggs B.L., and Spelsberg T.C. Skeletal effects of estrogen. Endocr. Rev. 15 3 (1994) 275-300
3. Pettersson K., and Gustafsson J.A. Role of estrogen receptor beta in estrogen action. Annu. Rev. Physiol. 63 (2001) 165-192
4. Deroo B.J., and Korach K.S. Estrogen receptor and human disease. J. Clin. Invest. 116 3 (2006) 561-570
5. Allred D.C., Mohsin S.K., and Fuqua S.A. Histological and biological evolution of human premalignant breast disease. Endocr. Relat. Cancer 8 1 (2001) 47-61
6. McDonnell D.P., and Norris J.D. Connections and regulation of the human estrogen receptor. Science 296 5573 (2002) 1642-1644
7. McKenna N.J., and O'Malley B.W. Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 108 4 (2002) 465-474
8. McKenna N.J., Lanz R.B., and O'Malley B.W. Nuclear receptor coregulators: cellular and molecular biology. Endocr. Rev. 20 3 (1999) 321-344
9. Kushner P.J., Agard D., Feng W.J., Lopez G., Schiau A., Uht R., Webb P., and Greene G. Oestrogen receptor function at classical and alternative response elements. Novartis Found. Symp. 230 (2000) 20-26
10. DeNardo D.G., Kim H.T., Hilsenbeck S., Cuba V., Tsimelzon A., and Brown P.H. Global gene expression analysis of estrogen receptor transcription factor cross talk in breast cancer: identification of estrogen-induced/activator protein-1-dependent genes. Mol. Endocrinol. 19 2 (2005) 362-378
11. Rubio M.F., Werbajh S., Cafferata E.G., Quaglino A., Colo G.P., Nojek I.M., Kordon E.C., Nahmod V.E., and Costas M.A. TNF-alpha enhances estrogen-induced cell proliferation of estrogen-dependent breast tumor cells through a complex containing nuclear factor-kappa B. Oncogene 25 9 (2006) 1367-1377
12. Safe S. Transcriptional activation of genes by 17beta-estradiol through estrogen receptor-Sp1 interactions. Vitam. Horm. 62 (2001) 231-252
13. Kim K., Barhoumi R., Burghardt R., and Safe S. Analysis of estrogen receptor alpha-Sp1 interactions in breast cancer cells by fluorescence resonance energy transfer. Mol. Endocrinol. 19 4 (2005) 843-854
14. Porter W., Saville B., Hoivik D., and Safe S. Functional synergy between the transcription factor Sp1 and the estrogen receptor. Mol. Endocrinol. 11 11 (1997) 1569-1580
15. Watanabe T., Inoue S., Hiroi H., Orimo A., Kawashima H., and Muramatsu M. Isolation of estrogen-responsive genes with a CpG island library. Mol. Cell. Biol. 18 1 (1998) 442-449
16. Dong L., Wang W., Wang F., Stoner M., Reed J.C., Harigai M., Kladde M., Vyhlidal C., and Safe S. Mechanisms of transcriptional activation of bcl-2 gene expression by 17β-estradiol in breast cancer cells. J. Biol. Chem. 274 45 (1999) 32099-32107
17. Stoner M., Wormke M., Saville B., Samudio I., Qin C., Abdelrahim M., and Safe S. Estrogen regulation of vascular endothelial growth factor gene expression in ZR-75 breast cancer cells through interaction of estrogen receptor alpha and SP proteins. Oncogene 23 5 (2004) 1052-1063
18. Fujita N., Kajita M., Taysavang P., and Wade P.A. Hormonal regulation of metastasis-associated protein 3 transcription in breast cancer cell. Mol. Endocrinol. 18 12 (2004) 2937-2949
19. Vyhlidal C., Samudio I., Kladde M.P., and Safe S. Transcriptional activation of transforming growth factor α by estradiol: requirement for both a GC-rich site and an estrogen response element half-site. J. Mol. Endocrinol. 24 3 (2000) 329-338
20. Kim K., Thu N., Saville B., and Safe S. Domains of estrogen receptor alpha (ERalpha) required for ERalpha/Sp1-mediated activation of GC-rich promoters by estrogens and antiestrogens in breast cancer cells. Mol. Endocrinol. 17 5 (2003) 804-817
21. Han W.D., Yu L., Lou F.D., Wang Q.S., Zhao Y.L., Shi Z.J., Jiao H.Y., and Zhou J.J. Cloning, sequence analysis and expression characterization of the full length cDNA for a novel leukemia-associated gene LRP16. Chin. J. Biochem. Mol. Biol. 17 2 (2001) 209-214
22. Han W.D., Mu Y.M., Lu X.C., Li X.J., Yu L., Song H.J., Li M., Lu J.M., Zhao Y.L., and Pan C.Y. Up-regulation of LRP16 mRNA by 17β-estradiol through activation of estrogen receptor α (ERα), but not estrogen receptor β (ERβ), and promotes human breast cancer MCF-7 cell proliferation: a preliminary report. Endocr. Relat. Cancer 10 2 (2003) 215-222
23. Han W.D., Li Q., Zhao Y.L., Mu Y.M., Li X., Song H.J., and Lu Z.Q. Inhibition of cell proliferation by small interference RNA against LRP16 gene in human breast cancer MCF-7 cells. Chin. J. Biochem. Mol. Biol. 21 1 (2005) 113-119
24. Liao D.X., Han W.D., Zhao Y.L., Pu Y.D., Mu Y.M., Luo C.H., and Li X.H. Expression and clinical significance of LRP16 gene in human breast cancer. Ai Zheng 25 7 (2006) 866-870
25. Zhao Y.L., Han W.D., Li Q., Mu Y.M., Lu X.C., Yu L., Song H.J., Li X., Lu J.M., and Pan C.Y. Mechanisms of transcripitional regulation of LRP16 gene expression by 17β-estradiol in MCF-7 human breast cancer cells. J. Mol. Endocriol. 34 1 (2005) 77-89
26. Norris J.D., Fan D., Stallcup M.R., and McDonnell D.P. Enhancement of estrogen receptor transcriptional activity by the coactivator GRIP-1 hightlights the role of activation function 2 in determining estrogen receptor pharmacology. J. Biol. Chem. 273 12 (1998) 6679-6688
27. Khan S., Abdelrahim M., Samudio I., and Safe S. Estrogen receptor/Sp1 complexes are required for induction of cad gene expression by 17β-estradiol in breast cancer cells. Endocrinology 144 6 (2003) 2325-2335
28. Sun G., Porter W., and Safe S. Estrogen-induced retinoic acid receptor alpha 1 gene expression: role of estrogen receptor-Sp1 complex. Mol. Endocrinol. 12 6 (1998) 882-890
29. Wang F., Samudio I., and Safe S. Transcriptional activation of cathepsinD gene expression by 17β-estradiol: mechanism of aryl hydrocarbon receptor-mediated inhibition. Mol. Cell. Endocrinol. 172 1-2 (2001) 91-103
30. Xie W., Duan R., and Safe S. Estrogen induces adenosine deaminase gene expression in MCF-7 human breast cancer cells: role of estrogen receptor-Sp1 interactions. Endocrinology 140 1 (1999) 219-227
31. Augereau P., Miralles F., Cavailles V., Gaudelet C., Parker M., and Rochefort H. Characterization of the proximal estrogen-responsive element of human cathepsin D gene. Mol. Endocrinol. 8 6 (1994) 693-730
32. Abdelrahim M., Samudio I., Smith R., Burghardt R., and Safe S. Small inhibitory RNA duplexes for Sp1 mRNA block basal and estrogen-induced gene expression and cell cycle progressionin MCF-7 breast cancer cells. J. Biol. Chem. 277 32 (2002) 28815-28822
33. Duan R., Porter W., Samudio I., Vyhlidal C., Kladde M., and Safe S. Transcriptional activation of c-fos protooncogene by 17b-estradiol: mechanism of aryl hydrocarbon receptor-mediated inhibition. Mol. Endocrinol. 13 9 (1999) 1511-1521
34. Ngwenya S., and Safe S. Cell context-dependent differences in the induction of E2F-1 gene expression by 17beta-estradiol in MCF-7 and ZR-75 cells. Endocrinology 144 5 (2003) 1675-1685
35. Saville B., Wormke M., Wang F., Nguyen T., Enmark E., Kuiper G., Gustafsson J.A., and Safe S. Ligand-Cell-, and estrogen receptor subtype (alpha/beta)-dependent activation at GC-rich (Sp1) promoter elements. J. Biol. Chem. 275 8 (2000) 5379-5387
36. Zwijsen R.M., Wientjens E., Klompmaker R., van der Sman J., Bernards R., and Michalides R.J. CDK-independent activation of estrogen receptor by cyclin D1. Cell 88 3 (1997) 405-415
37. Sanchez H.B., Yieh L., and Osborne T.F. Cooperation by sterol regulatory element-binding protein and Sp1 in sterol regulation of low density lipoprotein receptor gene. J. Biol. Chem. 270 3 (1995) 1161-1169
38. Wagner S., and Green M.R. HTLV-I Tax protein stimulation of DNA binding of bZIP proteins by enhancing dimerization. Science 262 5132 (1993) 395-399
39. Dishart D., Schnur N., Klan N., Werz O., Steinhilber D., Samuelsson B., and Radmark O. GC-rich sequences in the 5-lipoxygenase gene promoter are required for expression in Mono Mac 6 cells, characterization of a novel Sp1 binding site. Biochim. Biophys. Acta 1738 1-3 (2005) 37-47
40. Gui J., Song Y., Han N.L., Zhou S.F., and Sheu F.S. Involvement of the GC-rich sequence and specific proteins (Sp1/Sp3) in the basal transcription activity of neurogranin gene. Biochem. Biophys. Res. Commun. 345 1 (2006) 124-132
41. Higgins K.J., Abdelrahim M., Liu S., Yoon K., and Safe S. Regulation of vascular endothelial growth factor receptor-2 expression in pancreatic cancer cells by Sp proteins. Biochem. Biophys. Res. Commun. 345 1 (2006) 292-301
42. Smith C.L., and ÓMalley B.W. Coregulator function: a key to understanding tissue specificity of selective receptor modulators. Endocr. Rev. 25 1 (2004) 45-71
43. Hall J.M., and McDonnell D.P. Coregulators in nuclear estrogen receptor action: from concept to therapeutic targeting. Mol. Interv. 5 6 (2005) 343-357
44. Petz L.N., and Nardulli A.M. Sp1 binding sites and an estrogen response element half-site are involved in regulation of the human progesterone receptor A promoter. Mol. Endocrinol. 14 7 (2000) 972-985